October 8th.
Su City, Industrial Park.
Chen Yu arrived in front of the newly completed Huanyu Pharmaceutical Company.
Huanyu Pharmaceutical Company was a pharmaceutical company established by Chen Yu with an investment of 100 million yuan, focusing on chemical pharmaceuticals and biological pharmaceuticals.
The company has both raw material drug production bases and pharmaceutical production bases.
Looking from afar.
Modern factories, dotted with stars, stood majestically.
Lin Fei, the general manager of Huanyu Pharmaceutical Company, led Chen Yu on a tour of the company.
There are many factories in the company.
Raw material warehouse, oral dosage production workshop, mixing workshop, tablet pressing workshop, coating workshop, inner packaging workshop, outer packaging workshop, sterile workshop, finished product workshop, sterile laboratory, etc., all available.
Every workshop has many automated equipment and advanced instruments.
Seeing this, Chen Yu nodded in satisfaction.
Lin Fei introduced: "Mr. Chen, the first phase project of Huanyu Pharmaceutical Company covers an area of 1 square kilometer and was constructed by Xia State Construction Group Company through bidding.
Under their strong infrastructure capabilities.
In just three months, the company was completed and passed acceptance.
In addition to these workshops.
Huanyu Pharmaceutical Company has administrative departments such as human resources department, finance department, quality department, production department, engineering department, production department, operation department, procurement department, logistics department, etc.
It has 12 large-scale factories, 2 distribution centers, and a total of 1,000 employees..."
Hearing the introduction.
Chen Yu smiled slightly.
There are many biopharmaceutical companies in Su City.
There are more than 2,000 companies, big and small.
The city has been benchmarking itself against Boston, the "Global Pharma Valley", striving to create a world-renowned "Xia State Pharma Valley".
The current scale of Huanyu Pharmaceutical Company is only considered average in Su City.
However...
Waiting to solve the funding problem later.
Huanyu Pharmaceutical Company will launch the second phase construction project and the third phase construction project to continue expanding its scale.
Chen Yu first visited the company's raw material drug production base.
There are many workshops in this base.
Chemical raw material warehouse, raw material synthesis workshop, raw and auxiliary material workshop, hazardous chemical workshop, hazardous waste workshop, tank area, supporting comprehensive warehouse, etc., all available.
Lin Fei introduced: "Mr. Chen, all the production lines in the company's raw material drug production base meet the standards of the international CGMP production platform.
Under our full efforts, we can produce 30 tons of raw materials per year."
"Very good!"
Chen Yu was very satisfied.
China's top raw material drug production bases only produce around 150 tons of raw materials per year.
The scale of Huanyu Pharmaceutical's raw material drugs has already reached one-fifth of these enterprises.
Next.
The two came to the company's biological drug production base.
Inside the base, various advanced equipment are lined up.
Ultra-clean preparation aseptic filling line, aseptic lyophilized preparation production line, bioreactor production line, antibody drug research and development production line, cell culture production line, vaccine production line, etc., all available.
Lin Fei introduced: "Mr. Chen, the company's biological drug production base has two of the most advanced antibody drug large-scale research and development production lines in China, ten 5,000-liter single-use bioreactor production lines, the top purification production line in China, and supporting ultra-clean preparation filling lines.
The cell culture scale of the base reaches 100,000 liters.
The ADC drug research and development conjugation specifications are also among the best in China.
The base's bulk drug production capacity is as high as 500 million doses!"
Chen Yu nodded first, then asked: "The production of raw material drugs and pharmaceutical preparations requires the use of large quantities of chemical drugs or organic solvents, which will produce a large amount of waste liquid.
How do you handle environmental pollution and waste disposal?"
"Don't worry, Mr. Chen!"
Lin Fei introduced: "The company has a wastewater treatment facility with a treatment capacity of 1,000 tons, as well as supporting high-concentration thick wastewater pre-treatment facilities, which fully meet the standards of the national three-waste treatment project!"
Hearing this.
Chen Yu exclaimed.
The newly established Huanyu Pharmaceutical Company focuses on raw material drug research and development, biological drug research and development, antibodies and vaccines, cell therapy, gene therapy, and other directions, and will definitely become a well-known pharmaceutical company in China in the future.
…
Moments later.
Lin Fei also took Chen Yu to visit the company's talent apartments, dining and leisure, and commercial areas.
Finally, the two came to Huanyu Laboratory.
Huanyu Laboratory was built with an investment of 50 million yuan and belongs to Chen Yu's personal laboratory.
The laboratory focuses on pharmaceuticals.
Animal experiment center, drug research and development room, physical and chemical room, microscope room, precision instrument room, liquid phase room, gas phase room, balance room, clean room, high temperature room, preparation room, pulverizing room, waste liquid room, sampling room, constant temperature warehouse, cool warehouse, etc., all available.
Gel electrophoresis instrument, Nan0300, ABI-StepOne-Plus fluorescent QuantStudio3, PCR amplification instrument, cell counter, CO2 incubator, optical microscope, fluorescent microscope, liquid nitrogen storage tank, flow cytometer, and other advanced scientific research equipment are all available.
Lin Fei introduced: "Mr. Chen, Huanyu Laboratory can carry out a large number of basic research projects, complete single-cell sequencing, molecular experiments, animal modeling, pathological experiments, cell experiments, and other full-process research and development links.
From now on, you can engage in research projects in Huanyu Laboratory.
After developing new drugs and obtaining market approval.
Huanyu Pharmaceutical Company will be responsible for the production and sales of new drugs.
As soon as he finished speaking.
Chen Yu nodded in satisfaction.
Lin Fei is a professional talent he hired at a high salary, responsible for managing Huanyu Pharmaceutical Company.
In just a few months.
The company's basic framework has been established and is operating in an orderly manner.
This is inseparable from Lin Fei's outstanding ability.
He asked: "Manager Lin, the company probably has very little money left in its account, right?"
"That's right!"
Lin Fei replied honestly: "Huanyu Pharmaceutical Company has not yet launched any new drugs, so it can only take some pharmaceutical processing and production orders from other pharmaceutical companies.
But relying on processing to make money is simply not enough.
Without any surprises, the company's current funds will last at most two months."
Chen Yu said frankly: "Don't worry about the money, I will transfer a sum of money to the company in two months.
Next year, the universal artificial blood will be able to be marketed.
At that time, just producing universal artificial blood will make the company earn a fortune!"
"Yes, Mr. Chen!"
Lin Fei nodded with excitement.
As a practitioner in the pharmaceutical field.
He naturally knows the "future" contained in universal artificial blood.
To put it bluntly.
In the future, Huanyu Pharmaceutical will only produce this one drug, which will be enough for the company to eat for a lifetime!